Sareum Holdings (SAR) RNS Announcements

Add to Alert list
Date Time Source Announcement
15 Feb 2024 07:00 AM
RNS
Update on SDC-1801 Clinical Trial Progress
02 Jan 2024 07:00 AM
RNS
Development and commercialisation licence SRA737
14 Dec 2023 03:35 PM
RNS
Results of AGM
14 Dec 2023 07:00 AM
RNS
Annual General Meeting Statement
23 Nov 2023 07:00 AM
RNS
Drawdown of Equity Prepayment Facility
21 Nov 2023 07:00 AM
RNS
Notice of AGM, Annual Report and Accounts
09 Nov 2023 07:00 AM
RNS
Initiation of food effects study for SDC-1801
08 Nov 2023 03:03 PM
RNS
Director Dealings
03 Nov 2023 07:05 AM
RNS
Sareum enhances SDC-1801 patent protection
02 Nov 2023 02:48 PM
RNS
Exercise of Share Options and Director Dealings
09 Oct 2023 07:00 AM
RNS
Final Results for the Year Ended 30 June 2023
03 Oct 2023 07:00 AM
RNS
Notice of Results and Investor Presentation
06 Sep 2023 07:00 AM
RNS
Director's Dealing
05 Sep 2023 07:00 AM
RNS
Director Dealing
04 Sep 2023 07:00 AM
RNS
Dosing of first subjects in MAD Phase 1a trial
16 Aug 2023 07:00 AM
RNS
Update on financial and operational progress
03 Aug 2023 07:00 AM
RNS
Equity Prepayment Facility of up to £5 million
26 Jun 2023 07:00 AM
RNS
Sareum Announces Two New Granted Patents
06 Jun 2023 07:00 AM
RNS
Dosing commences in Phase 1a trial of SDC-801
18 May 2023 07:00 AM
RNS
Phase 1a clinical trial for SDC-1801
05 May 2023 09:20 AM
RNS
Approval to initiate Phase 1 clinical trial
22 Mar 2023 07:00 AM
RNS
Half-Year Report
15 Mar 2023 07:01 AM
RNS
Update on SDC-1801
15 Mar 2023 07:00 AM
RNS
Notice of Half-Year Results
06 Mar 2023 07:00 AM
RNS
Update on SRA737
29 Dec 2022 03:14 PM
RNS
Director/PDMR Shareholding
16 Dec 2022 03:29 PM
RNS
Results of AGM
16 Dec 2022 07:00 AM
RNS
AGM Statement
24 Nov 2022 07:00 AM
RNS
Notice of AGM, Annual Report and Accounts
21 Nov 2022 07:00 AM
RNS
Sareum notes publication of SRA737 clinical data
09 Nov 2022 04:41 PM
RNS
Second Price Monitoring Extn
09 Nov 2022 04:35 PM
RNS
Price Monitoring Extension
09 Nov 2022 02:05 PM
RNS
Second Price Monitoring Extn
09 Nov 2022 02:00 PM
RNS
Price Monitoring Extension
09 Nov 2022 11:05 AM
RNS
Second Price Monitoring Extn
09 Nov 2022 11:00 AM
RNS
Price Monitoring Extension
09 Nov 2022 09:05 AM
RNS
Second Price Monitoring Extn
09 Nov 2022 09:00 AM
RNS
Price Monitoring Extension
08 Nov 2022 05:23 PM
RNS
Update on SDC-1801 CTA Application
24 Oct 2022 07:00 AM
RNS
Final Results for the Year Ended 30 June 2022
12 Oct 2022 07:00 AM
RNS
Update on SRA737
30 Sep 2022 04:41 PM
RNS
Second Price Monitoring Extn
30 Sep 2022 04:36 PM
RNS
Price Monitoring Extension
12 Sep 2022 07:00 AM
RNS
Sareum notes FDA approval of first TYK2 Inhibitor
28 Jul 2022 07:00 AM
RNS
CTA application to MHRA and Corporate Update
04 Jul 2022 07:00 AM
RNS
Sareum notes GSK's completed acquisition of Sierra
26 Apr 2022 07:00 AM
RNS
Sareum to Present at BioTrinity 2022 Conference
13 Apr 2022 04:00 PM
RNS
Sareum notes acquisition of Sierra Oncology by GSK
13 Apr 2022 11:05 AM
RNS
Second Price Monitoring Extn
13 Apr 2022 11:00 AM
RNS
Price Monitoring Extension
UK 100

Latest directors dealings